Company / EPS (Basic)
Minerva Neurosciences, Inc. EPS (Basic) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$4.61
FY2024
5-year range
-$9.35 / $0.05
FY2020-FY2024
Trend
+23.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-9.35 to $-4.61 over the past 2 years.
Based on SEC 10-K filings.
-4.61 in FY2024.
Improved from $-9.35 to $-4.61 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (basic) increased 23.3% year-over-year.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$4.61 | +23.3% |
| FY2023 | -$6.01 | +35.7% |
| FY2022 | -$9.35 | -18800.0% |
| FY2021 | $0.05 | +102.7% |
| FY2020 | -$1.85 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026